Initiating Buprenorphine-based MAT in Emergency Departments
Patients receiving care in emergency departments who have untreated opioid use disorder are referred to a provider for long-term buprenorphine-based MAT. This referral is accompanied by initial doses of buprenorphine or a short-term prescription that can be filled right away. The patient can begin treatment immediately, instead of waiting several says for their appointment with new provider.
Why this strategy works Even if a patient in the emergency department is very eager to begin MAT, receiving a referral and possibly waiting several days to begin care greatly decreases the likelihood that this patient will successfully engage in care. Providing an initial dose of buprenorphine in the emergency department eliminates these delays in care and allows the patient to begin experiencing the benefits of MAT immediately. Subsequent daily doses provided by the hospital (either by prescription or by supervised consumption at the hospital pharmacy) serve as a "bridge," providing the patient with care on a temporary basis, if necessary, while a referral and "warm hand off" to physician who can continue to provide MAT is carried out, |
Initiating buprenorphine-based MAT in emergency departments works best when: There is no broadly accepted "best practice" for initiating patients onto buprenorphine-based MAT in an emergency department. This intervention is very new, and researchers are still studying how best to serve patients' needs and assist them in engaging with care. Patients who are initiate in the emergency department are very likely there because they have experienced an overdose crisis. It can be expected that such an experience may change the meaning of treatment for these patients, and the value of treatment may change in an inconsistent or counter-intuitive way over time,
What we do know, however, is that each instance of engagement in MAT, even if the patient eventually drops out of care, predicts higher success the next time treatment is sought. Furthermore, providing "bridging" doses of MAT medications to individuals seeking treatment greatly improves patient engagement in MAT care during treatment initiation--a key moment for those with opioid use disorder, when maintaining trust and stability is of utmost importance. |
Initiating buprenorphine-based MAT in emergency departments--What the research says
|
|